IEUX.AS vs. XGEN.DE

Last updated Apr 2, 2026

Compare and contrast key facts about iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE).

IEUX.AS and XGEN.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IEUX.AS is a passively managed fund by iShares that tracks the performance of the MSCI Europe Ex UK NR EUR. It was launched on Jun 2, 2006. XGEN.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. It was launched on Jul 12, 2022. Both IEUX.AS and XGEN.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

IEUX.AS vs. XGEN.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). The values are adjusted to include any dividend payments, if applicable.

IEUX.AS vs. XGEN.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
IEUX.AS iShares MSCI Europe ex-UK UCITS ETF	-0.16%	19.55%	7.52%	17.22%	1.58%
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-4.14%	7.38%	2.95%	-5.84%	-9.98%

Returns By Period

In the year-to-date period, IEUX.AS achieves a -0.16% return, which is significantly higher than XGEN.DE's -4.14% return.

IEUX.AS

• 1D: 2.64%
• 1M: -4.03%
• YTD: -0.16%
• 6M: 5.11%
• 1Y: 11.63%
• 3Y*: 11.08%
• 5Y*: 8.71%
• 10Y*: 9.07%

XGEN.DE

• 1D: 2.28%
• 1M: -1.91%
• YTD: -4.14%
• 6M: 5.14%
• 1Y: 11.86%
• 3Y*: 0.68%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IEUX.AS vs. XGEN.DE - Expense Ratio Comparison

IEUX.AS has a 0.40% expense ratio, which is higher than XGEN.DE's 0.30% expense ratio.

IEUX.AS

iShares MSCI Europe ex-UK UCITS ETF

XGEN.DE

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

Return for Risk

IEUX.AS vs. XGEN.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IEUX.AS

IEUX.AS Risk / Return Rank: 50
IEUX.AS Sharpe Ratio Rank: 36
IEUX.AS Sortino Ratio Rank: 34
IEUX.AS Omega Ratio Rank: 35
IEUX.AS Calmar Ratio Rank: 73
IEUX.AS Martin Ratio Rank: 73

XGEN.DE

XGEN.DE Risk / Return Rank: 30
XGEN.DE Sharpe Ratio Rank: 28
XGEN.DE Sortino Ratio Rank: 28
XGEN.DE Omega Ratio Rank: 26
XGEN.DE Calmar Ratio Rank: 34
XGEN.DE Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IEUX.AS vs. XGEN.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IEUX.AS	XGEN.DE	Difference
Sharpe ratio Return per unit of total volatility	0.74	0.57	+0.17
Sortino ratio Return per unit of downside risk	1.05	0.89	+0.16
Omega ratio Gain probability vs. loss probability	1.16	1.11	+0.04
Calmar ratio Return relative to maximum drawdown	2.13	0.97	+1.16
Martin ratio Return relative to average drawdown	8.44	2.79	+5.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IEUX.AS vs. XGEN.DE - Sharpe Ratio Comparison

The current IEUX.AS Sharpe Ratio is 0.74, which is higher than the XGEN.DE Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of IEUX.AS and XGEN.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	IEUX.AS	XGEN.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.74	0.57	+0.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.59	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.57	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	-0.15	+0.43

Correlation

The correlation between IEUX.AS and XGEN.DE is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

IEUX.AS vs. XGEN.DE - Dividend Comparison

IEUX.AS's dividend yield for the trailing twelve months is around 2.13%, while XGEN.DE has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IEUX.AS iShares MSCI Europe ex-UK UCITS ETF	2.13%	2.15%	2.36%	2.37%	2.34%	1.62%	1.43%	2.33%	2.65%	2.27%	2.31%	2.16%
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

IEUX.AS vs. XGEN.DE - Drawdown Comparison

The maximum IEUX.AS drawdown since its inception was -60.28%, which is greater than XGEN.DE's maximum drawdown of -37.58%. Use the drawdown chart below to compare losses from any high point for IEUX.AS and XGEN.DE.

Drawdown Indicators

	IEUX.AS	XGEN.DE	Difference
Max Drawdown Largest peak-to-trough decline	-60.28%	-37.58%	-22.70%
Max Drawdown (1Y) Largest decline over 1 year	-12.05%	-14.88%	+2.83%
Max Drawdown (5Y) Largest decline over 5 years	-22.47%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-34.79%	—	—
Current Drawdown Current decline from peak	-5.85%	-17.22%	+11.37%
Average Drawdown Average peak-to-trough decline	-14.79%	-19.46%	+4.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.51%	4.61%	-2.10%

Volatility

IEUX.AS vs. XGEN.DE - Volatility Comparison

iShares MSCI Europe ex-UK UCITS ETF (IEUX.AS) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) have volatilities of 6.02% and 6.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IEUX.AS	XGEN.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.02%	6.10%	-0.08%
Volatility (6M) Calculated over the trailing 6-month period	9.53%	13.02%	-3.49%
Volatility (1Y) Calculated over the trailing 1-year period	15.58%	20.88%	-5.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.75%	18.50%	-3.75%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.65%	18.50%	-2.85%